The store will not work correctly when cookies are disabled.
For any custom sample collection or services inquiries, please call us at 301-417-4343 to Learn more!
Human Tissue Microarray (PAN040-01A)
Panceatic tumor tissue microarray - 2 cores per case
- 19 PDA cases
- 1 Acinar cell carcinoma case
More Information
| Species |
Human |
| Section Thickness |
5 µm |
| Fixative |
Formalin |
| Total Cases |
20 |
| Total Cores |
40 |
| Core Diameter |
1.5 mm |
| Storage |
Short term RT |
| Usage |
For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
USBIOLAB
- A
- PA
- PA
- PA
- PA
- PA
- PA
- PA
- PA
- B
- PA
- PA
- PA
- PA
- PA
- PA
- PA
- PA
- C
- PA
- PA
- PA
- PA
- PA
- PA
- PA
- PA
- D
- PA
- PA
- PA
- PA
- PA
- PA
- PA
- PA
- E
- PA
- PA
- PA
- PA
- PA
- PA
- PA
- PA
- PA
-
No.
-
Map ID
-
Age
-
Sex
-
Organ
-
Pathology Diagnosis
-
Grade
-
TNM
-
Stage
-
Type
-
Block ID
| No. |
Map ID |
Age |
Sex |
Organ |
Pathology Diagnosis |
Grade |
TNM |
Stage |
Type |
Block ID |
|
1
|
A1
|
62
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
-
|
-
|
Malignant Primary
|
1233865C
|
|
2
|
A2
|
62
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
-
|
-
|
Malignant Primary
|
1233865C
|
|
3
|
A3
|
65
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G3
|
T2N2M0
|
IV
|
Malignant Primary
|
3108-16
|
|
4
|
A4
|
65
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G3
|
T2N2M0
|
IV
|
Malignant Primary
|
3108-16
|
|
5
|
A5
|
58
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G1
|
T1N1M0
|
IIB
|
Malignant Primary
|
3383-17
|
|
6
|
A6
|
58
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G1
|
T1N1M0
|
IIB
|
Malignant Primary
|
3383-17
|
|
7
|
A7
|
66
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N1M1
|
IV
|
Malignant Primary
|
P245
|
|
8
|
A8
|
66
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N1M1
|
IV
|
Malignant Primary
|
P245
|
|
9
|
B1
|
67
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T2N0M0
|
IB
|
Malignant Primary
|
P252
|
|
10
|
B2
|
67
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T2N0M0
|
IB
|
Malignant Primary
|
P252
|
|
11
|
B3
|
56
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N1M0
|
IIB
|
Malignant Primary
|
P292
|
|
12
|
B4
|
56
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N1M0
|
IIB
|
Malignant Primary
|
P292
|
|
13
|
B5
|
53
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
P320
|
|
14
|
B6
|
53
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
P320
|
|
15
|
B7
|
39
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T1N1M1
|
IV
|
Malignant Primary
|
P253
|
|
16
|
B8
|
39
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T1N1M1
|
IV
|
Malignant Primary
|
P253
|
|
17
|
C1
|
30
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N1M0
|
IIB
|
Malignant Primary
|
P302
|
|
18
|
C2
|
30
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N1M0
|
IIB
|
Malignant Primary
|
P302
|
|
19
|
C3
|
69
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
-
|
-
|
Malignant Primary
|
111
|
|
20
|
C4
|
69
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
-
|
-
|
Malignant Primary
|
111
|
|
21
|
C5
|
57
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G3
|
-
|
-
|
Malignant Primary
|
121
|
|
22
|
C6
|
57
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G3
|
-
|
-
|
Malignant Primary
|
121
|
|
23
|
C7
|
60
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
-
|
-
|
Malignant Primary
|
301
|
|
24
|
C8
|
60
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
-
|
-
|
Malignant Primary
|
301
|
|
25
|
D1
|
39
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G3
|
-
|
-
|
Malignant Primary
|
381
|
|
26
|
D2
|
39
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G3
|
-
|
-
|
Malignant Primary
|
381
|
|
27
|
D3
|
65
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
-
|
-
|
Malignant Primary
|
400
|
|
28
|
D4
|
65
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
-
|
-
|
Malignant Primary
|
400
|
|
29
|
D5
|
46
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
-
|
-
|
Malignant Primary
|
Y273
|
|
30
|
D6
|
46
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
-
|
-
|
Malignant Primary
|
Y273
|
|
31
|
D7
|
63
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
1506540-M
|
|
32
|
D8
|
63
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
1506540-M
|
|
33
|
E1
|
78
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
1516492-H
|
|
34
|
E2
|
78
|
F
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
1516492-H
|
|
35
|
E3
|
78
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
1530147-F
|
|
36
|
E4
|
78
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G2
|
T3N0M0
|
IIA
|
Malignant Primary
|
1530147-F
|
|
37
|
E5
|
68
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G1
|
T3N1M0
|
IIB
|
Malignant Primary
|
17-15029
|
|
38
|
E6
|
68
|
M
|
Pancreas
|
Pancreatic Ductal Adenocarcinoma (PDA)
|
G1
|
T3N1M0
|
IIB
|
Malignant Primary
|
17-15029
|
|
39
|
E7
|
55
|
F
|
Pancreas
|
�Acinar cell carcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
17-17947
|
|
40
|
E8
|
55
|
F
|
Pancreas
|
�Acinar cell carcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
17-17947
|
|
41
|
E9
|
|
|
|
Tissue Marker
|
|
|
|
|
|
Copyright © 2025 US Biolab • All Rights Reserved.
